OncLiveCAR T-Cell Therapy Shows Promise in Relapsed/Refractory MyelomaOncLiveBerdeja: bb2121 is a CAR-T product directed at BCMA that uses a 4-1BB costimulatory domain and it is for patients with relapsed/refractory multiple myeloma. We presented the c… Continue reading
Science MagazineFor postdocs looking to break into entrepreneurship, this MIT fellowship is helping light the wayScience MagazineAs Ronan McGovern was finishing up his Ph.D., he was eager to commercialize the energy-efficient seawater desalination proc… Continue reading
A New Study Committed to Promoting Efficient T Cell Proliferation with Biomaterial Scaffolds That Mimic Antigen …Digital JournalRecently, in a new study, a research team reported a replacement material-based T-cell expansion method that may help over… Continue reading
Controlled Environments Magazine |
Synthetic “Virus” Dispatched to Kill Bacteria
Controlled Environments Magazine “The way our synthetic virus works means that bacteria are less likely to become resistant to it. They also have an additional advantage over traditional antibiotics in that they don’t have to reach and hit a single target inside a bacterial cell to be … |
|
Rockefeller scientists develop system to model Huntington’s in human embryonic stem cells
News-Medical.net With new findings, scientists may be poised to break a long impasse in research on Huntington’s disease, a fatal hereditary disorder for which there is currently no treatment. One in 10,000 Americans suffer from the disease, and most begin to show … |